IDEX Biometrics ASA IDXAF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -4.36% | 162.46% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.36% | 162.46% | |||
| Cost of Revenue | 82.85% | -83.43% | |||
| Gross Profit | -68.00% | 126.71% | |||
| SG&A Expenses | -32.59% | 115.19% | |||
| Depreciation & Amortization | 3.04% | -47.54% | |||
| Other Operating Expenses | 20.43% | 4.32% | |||
| Total Operating Expenses | -6.63% | 31.31% | |||
| Operating Income | 6.78% | -26.76% | |||
| Income Before Tax | 75.91% | -41.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 75.91% | -41.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 75.91% | -41.52% | |||
| EBIT | 6.78% | -26.76% | |||
| EBITDA | 6.93% | -56.23% | |||
| EPS Basic | 78.57% | -4.23% | |||
| Normalized Basic EPS | 48.05% | -995.35% | |||
| EPS Diluted | 78.57% | 0.65% | |||
| Normalized Diluted EPS | 48.05% | -995.35% | |||
| Average Basic Shares Outstanding | 12.35% | 35.77% | |||
| Average Diluted Shares Outstanding | 12.35% | 35.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||